Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioblastoma × Sampling Studies × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Weight Loss 1 Preleukemia 1 Ovarian Neoplasms 1 Osteochondroma 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Nevus, Epithelioid and Spindle Cell 1 Myelodysplastic Syndromes 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Glioblastoma 1 Giant Cell Tumors 1 Fibrosis 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Carcinoma, Lobular 1 Carcinoma in Situ 1 Barrett Esophagus 1

Interventions

Temozolomide 230 Radiotherapy 105 Bevacizumab 89 Magnetic Resonance Spectroscopy 46 Radiation 40 pembrolizumab 28 Irinotecan 25 Lomustine 19 Radiosurgery 17 Nivolumab 17 Surgical Procedures, Operative 16 Carmustine 15 Aminolevulinic Acid 14 Erlotinib Hydrochloride 13 Specimen Handling 12 Drug Therapy 12 Chemotherapy, Adjuvant 12 Carboplatin 12 Radiotherapy, Intensity-Modulated 11 Cyclophosphamide 11 Blood Specimen Collection 11 sargramostim 10 Thalidomide 10 O(6)-benzylguanine 10 poly ICLC 8 Sunitinib 8 Filgrastim 8 Everolimus 8 Etoposide 8 Diet, Ketogenic 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07173829 2025-09-15

BORDEAUX-GLIO

University Hospital, Bordeaux

Not yet recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡